Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lum, Z. P.
Right arrow Articles by Sun, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lum, Z. P.
Right arrow Articles by Sun, A. M.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 40, Issue 11 1511-1516, Copyright © 1991 by American Diabetes Association

ARTICLES

Prolonged reversal of diabetic state in NOD mice by xenografts of microencapsulated rat islets

ZP Lum, IT Tai, M Krestow, J Norton, I Vacek and AM Sun
Department of Physiology, University of Toronto, Ontario, Canada.

Transplantation of the islets of Langerhans could be the most promising approach to the clinical treatment of insulin-dependent (type I) diabetes mellitus. In this study, we report on a modified encapsulation technique that produces small alginate-polylysine capsules (0.25-0.35 mm diam). In an in vitro study, both encapsulated and unencapsulated islets showed comparable responses to glucose challenge in terms of insulin secretion. With the new capsules, 16 spontaneously diabetic NOD mice received transplants of 800 encapsulated rat islets/animal. Nonfasting blood glucose concentration decreased from 24.4 +/- 1.4 to 4.0 +/- 1.3 mM. At 4 and 5 mo posttransplantation, the capsules were removed from 2 recipients. Both animals regressed to a hyperglycemic state after capsule removal. However, after another islet transplantation, normoglycemia was again restored in these 2 animals. In control mice, which received unencapsulated islets, the xenografts remained functional for less than 10 days. A high mortality rate was observed among these animals within 2 mo of the recurrence of the hyperglycemic state. Our results clearly indicate that encapsulation of pancreatic islets in the improved capsules can effectively prolong xenograft survival without immunosuppression in an animal model that mimics human type I diabetes mellitus.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 EndocrinologyHome page
R. Robitaille, J. Dusseault, N. Henley, L. Rosenberg, and J.-P. Halle
Insulin-Like Growth Factor II Allows Prolonged Blood Glucose Normalization with a Reduced Islet Cell Mass Transplantation
Endocrinology, July 1, 2003; 144(7): 3037 - 3045.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
V. F. Duvivier-Kali, A. Omer, R. J. Parent, J. J. O'Neil, and G. C. Weir
Complete Protection of Islets Against Allorejection and Autoimmunity by a Simple Barium-Alginate Membrane
Diabetes, August 1, 2001; 50(8): 1698 - 1705.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
D. Zhou, A. M. Sun, X. Li, S. N. Mamujee, I. Vacek, J. Georgiou, and M. B. Wheeler
In vitro and in vivo evaluation of insulin-producing beta TC6-F7 cells in microcapsules
Am J Physiol Cell Physiol, May 1, 1998; 274(5): C1356 - C1362.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1991 by the American Diabetes Association.